Advanced Intelligent Systems

Due to its ability to establish a pool of undetectable and latently infected cells that can initiate viral production through random reactivation, a cure to human immunodeficiency virus (HIV) infections has remained elusive. Many approaches have been proposed, including the "shock and kill" method where latency reversing agents (LRAs) are administered to reactivate latently infected cells out of latency and remove them through immune targeting and clearance, and the "block and lock" method where latency promoting agents (LPAs) are administered to inhibit reactivation and potentially induce a "deep latency" state where infected cells can no longer reactivate. Previous large scale drug screen studies have demonstrated a correlation between a compound's capability to modulate the fluctuations (or "noise") in HIV gene expression and its potential to modulate HIV latency. However, measurements of gene expression noise are labor- and cost-intensive. To circumvent these drawbacks, we trained a variational autoencoder (VAE) on a previously published large scale time-lapse fluorescence microscopy dataset, and performed an in silico screening of ~175,000 compounds for HIV latency modulators. Out of the top 113 predicted modulators that were experimentally tested, 16 latency reversing agent (LRA) synergizers and 2 latency promoting agents (LPAs) were confirmed, yielding an overall experimental hit rate of 15.9%. Our work demonstrates that in silico drug screening modalities, guided by existing large-scale experimental datasets, can yield high experimental hit rates, reducing costs incurred from labor-intensive wet lab-focused methodologies.

Designing transcutaneous skeletal muscle oxygenation (SmO2) sensors requires jointly optimizing source--detector geometry and wavelength selection while guaranteeing performance across populations that vary in subcutaneous fat thickness and skin pigmentation. We present a multi-fidelity Bayesian optimization (MFBO) framework that couples Monte Carlo light-transport simulations at two photon-count fidelities to a distributionally robust design objective. An autoregressive Gaussian-process surrogate learns the correlation between inexpensive low-photon-count and accurate high-photon-count simulations, and a cost-aware acquisition function decides both where and at what fidelity to sample. Robustness across the population is enforced with Conditional Value-at-Risk (CVaR) and entropic-risk (ERM) objectives that target worst-case subjects rather than the population average. On a five-layer forearm tissue model with anthropometric variability we find (i) a fidelity regime that is favorable for MFBO where the low-fidelity surrogate is rank-informative (Spearman {rho} = 0.84) but biased, at 100x lower cost; (ii) MFBO attains 23% higher robust sensitivity than a strong high-fidelity single-fidelity baseline at equal budget (p = 0.035), and avoids the optimistic bias that causes low-fidelity-only optimization to collapse when its designs are validated at high fidelity; (iii) CVaR/ERM objectives improve worst-case tail performance by {approx}23% relative to a mean objective without sacrificing average sensitivity; and (iv) discovered designs improve robust tail sensitivity by roughly 3--6x over commercial and heuristic optode layouts, with the largest gains in the high-fat and high-melanin subpopulations. The methodology bridges stochastic light-transport physics with sample-efficient machine-learning optimization and generalizes to cerebral oximetry, photodynamic therapy planning, and wearable physiological monitors.

Lipid Nanoparticles (LNPs) are widely used as delivery systems for nucleic acid therapeutics, where transfection efficiency is determined by both the identities of constituent lipid components and their composition ratios. While prior studies have focused on learning molecular representations for individual components, modeling how multiple components and their ratios jointly influence LNP performance remains underexplored. In this work, we propose STRATA, a framework that models molecule interaction between LNP components, which is known to contribute to LNP transfection efficiency. Our approach is built on two complementary views: (1) a ratio-centric view that captures interaction patterns induced by composition ratios through a transformer with a Ratio-induced Positional Embedding, and (2) a molecule-centric view that incorporates interaction-induced effects into structure-based molecule embeddings. By jointly training and aligning these views, our model integrates molecular structure and composition ratio within a unified framework that captures interaction-driven effects. Experiments demonstrate that our method improves prediction accuracy and generalization to unseen molecules and ratios, highlighting the effectiveness of our approach. Implementation code will be available after acceptance.

Single-molecule (SM) imaging (SMI)-based approaches have the powerful ability to capture receptor interactions, which are necessary for cell signaling, in their native live-cell environment. Yet, due to substoichiometric labeling, SMI generally provides only partial information on these interactions. We developed Deep-FISIK, which utilizes graph neural networks and multi-head attention for message-passing, to predict from SMI data the kinetics of homotypic interactions of the full receptor system. The input to Deep-FISIK are the SM detections in SMI experiments, without the need for explicit tracking. Thus, Deep-FISIK is compatible with labeling a higher fraction of receptors in the SMI experiments, increasing the prediction accuracy of the interaction kinetics parameters. The performance of Deep-FISIK is robust in the presence of a variety of deviations from the training data, indicating the applicability of Deep-FISIK to many receptor systems and SMI experiments.

Deep generative models have become a leading approach for designing therapeutic molecules, yet efficiently exploring vast biomolecular sequence spaces remains difficult, particularly for targets with limited training data. The prior distribution that seeds a generative model shapes which regions of sequence space it explores, and recent work suggests that non-classical distributions sampled from quantum processors can serve as a structured alternative to the factorised Gaussian priors used by default. Whether such priors help on complex biological design tasks has been largely untested. Here we present the first end-to-end hybrid quantum-classical pipeline for de novo design of MHC class I-binding peptides, coupling a generative adversarial network (GAN) to latent vectors sampled from a real photonic quantum processor. Tested in silico across 131 HLA alleles, quantum-derived priors increased the yield of predicted strong binders, with the largest relative gains for understudied alleles where classical baselines perform worst. We selected three understudied alleles for further evaluation, finding that large gains coincided with broader sequence exploration at non-anchor positions while anchor specificity was preserved. On these three alleles, we validated the designs in vitro using peptide-MHC stability ELISAs, confirming that quantum-designed peptides are potent stabilisers of peptide-MHC class I complexes. These results establish structured, hardware-realisable non-classical priors as a useful inductive bias for generative peptide design, with direct relevance to personalised immunotherapies and vaccines.

Here we introduce OpenEvo, a fully open-source, low-cost turbidostat platform for automated continuous culture and directed evolution experiments. Existing tools are expensive, complex, or lack open-source hardware; OpenEvo addresses this gap. OpenEvo is a complete, fully automated evolution platform with detailed, illustrated construction instructions for beginners, open-source software and firmware, and a single device priced around $300. An optional PC-based version offers enhanced functionality, including remote access, programmable evolution cycles, programmable LED stimulation, and a data visualization tool. OpenEvo can cycle through three types of media for positive, negative, and neutral selection conditions, supporting a wide range of experimental designs. We validate the use of OpenEvo by evolving H. volcanii to grow from 15% to 12% salt over ~150 cycles, ~1,000 hours. Evolved cells grew 36% faster than wild-type at 12% salt. Whole-genome sequencing of adapted cells found SNPs and large deletions. We also demonstrate positive and negative selection using the OpenEvo LEDs to drive optogenetics via a Phytochrome B-based optogenetic tool, with light as the selection stimulus during over 4000 hours of growth. OpenEvo lowers the technical and cost barriers for continuous evolution experiments, serves as a teaching tool, and is designed to grow an open community of users who share modifications.

Elephants and other large mammals produce low-frequency vocalizations extending well below the 20 Hz lower limit of human hearing, a regime known as infrasound. These rumbles serve vital social and reproductive functions over distances of several kilometers, yet they are inaudible to human observers and cannot be reproduced by conventional small loudspeakers. We present a complete signal-processing pipeline that renders sub-20 Hz elephant rumbles perceptible through a small loudspeaker by exploiting the missing-fundamental psychoacoustic effect. Butterworth bandpass filters isolate the infrasonic content; a full-wave integrator nonlinear device (NLD) generates the harmonic series required for virtual pitch perception; and a hysteresis-comparator fundamental-frequency estimator normalizes the NLD output. The pipeline was validated on African elephant field recordings and deployed on a credit-card-sized, low-cost single-board computer with an infrasound microphone and a small Bluetooth loudspeaker, demonstrating live operation in the field. The processed output shows a 10 dB to 15 dB elevation in the loudspeakers efficient band during call segments compared with background. The system enables zoo visitors and wildlife observers to perceive elephant rumbles in real time, opening new avenues for behavioral studies and public engagement with animal communication.

Existing interfaces modulate user experience through visual, auditory, and haptic channels, but direct physiological modulation, which programmatically alters a user's internal state, remains largely underexplored. We present a wearable sonophoresis patch that uses low-frequency acoustic stimulation to deliver psychoactive substances transdermally, and evaluate its potential for programmable physiological modulation in HCI. We tested this in a double-blinded study (N=26) delivering 100 mg caffeine versus sham control, recording physiological signals during rest and a sustained attention task (SART). The planned comparison for heart rate standard deviation during rest was significant (HR-SD p=0.025, d=1.48), with the caffeine group showing suppressed HR~SD consistent with sympathetic activation. Mean heart rate at rest was not significant (p=0.365), but exploratory analyses during the cognitive task revealed significant cardiovascular divergence: heart rate (p=0.003) and heart rate standard deviation (p=0.027) both moved in directions consistent with systemic caffeine delivery, with effects emerging within minutes of device activation and a sustained group effect across all task rounds (p<0.001). These results provide indirect evidence that wearable sonophoresis can deliver substances to modulate user physiology, opening the design space for on-skin chemical interfaces that adapt delivery in real time to change the user's physiological state on demand.

Optogenetic control enables light-actuated regulation of gene expression and provides a programmable interface between living cells and electronic systems. However, routine prototyping of optogenetic constructs remains limited by infrastructure. Existing closed-loop platforms often require chemostats, microfluidics, robotic handling, or custom optical sensors, which can increase cost, reduce accessibility, or constrain measurement performance. Here, we present LEMOS 2.0, an updated LED-Embedded Microplate for Optogenetic Studies, a low-cost device for optogenetic stimulation and gene-circuit characterization inside standard off-the-shelf microplate readers. LEMOS 2.0 builds on the original LEMOS platform by increasing throughput from 16 to 32 microwells and reducing light leakage between adjacent microwells, allowing dark conditions to be used as an additional illumination state. The device consists of a 3D-printed frame, individually addressable LEDs positioned next to each microwell, a rechargeable battery, and an onboard microcontroller for Bluetooth-based wireless communication. Biocompatible polydimethylsiloxane microwells are cast directly into the device by replica molding, allowing bacterial cultures to be stimulated while optical density and fluorescence are measured by the microplate reader. This protocol describes the full LEMOS 2.0 workflow, including device fabrication, circuit assembly, Arduino programming, PDMS microwell casting, plate-reader setup, strain and culture preparation, automated experiment execution, device cleanup, and fluorescence/OD600 data analysis. As a demonstration, the protocol uses the CcaSR optogenetic system, in which sfGFP expression is activated by green light and repressed by red light. LEMOS 2.0 is intended to make optogenetic perturbation and gene-expression characterization more accessible to wet-lab users, enabling faster design-build-test-learn cycles without requiring specialized bioreactor or microfluidic infrastructure.

Tissues are spatially organized systems in which cell states, functions and interactions vary across spatial coordinates, forming compartments or gradients shaped by local microenvironments. Understanding how molecular features and cell-cell interactions change across space and time is central to studying development, homeostasis and disease. Addressing these questions increasingly requires the integration of multi-modal spatial data, which provides complementary views of cellular and structural organization. However, existing computational approaches typically combine modalities by weighting them equally, overlooking domain-specific technical artifacts, differences in spatial resolution and non-overlapping feature spaces. In addition, methods for spatial cell-cell communication analysis are largely developed for single-modality settings and do not model how interactions vary across the tissue. To address these gaps, we introduce LYNX, a deep generative framework that learns a shared latent representation of spatial dynamics from joint-measured modalities in the 2D or 3D domain, to provide a unified coordinate system for modeling how cell-cell interactions, phenotypes, and molecular programs vary along continuous spatial gradients. LYNX identifies spatial programs difficult to resolve with existing approaches, including metabolically coupled porto-central interaction remodeling in liver, recovery of degraded proteomic signals along the cortico-medullary axis in thymus, and branching trajectories towards DCIS and invasive niches marked by distinct stromal activation-states and immune-tumor crosstalk in breast tumor microenvironment. We demonstrate that LYNX robustly infers spatially resolved gradients, maps functional compartments and cell-cell interactions along spatial axes and is compatible across diverse spatial profiling technologies, modalities, and resolution disparities. LYNX provides a foundational and scalable framework to advance our understanding of healthy tissue physiology and to decode temporal evolution of complex diseases.

Vascular chips have advanced endothelial mechanobiology by enabling controlled responses to hemodynamic cues, yet disease-relevant wall shear stress (WSS) modeling remains limited. Simplified one-dimensional flow shear systems, designed mainly for physiological mechanobiology, miss the topological organization of pathological flow, whereas patient-specific vascular models capture complex hemodynamics but sacrifice generality and imaging compatibility. Here we develop a programmable vascular chip that converts disease-associated WSS topology into a physiologically parameterized experimental input. The device reconstructs a representative pathological shear-topology field on endothelial layer, supports stationary and physiologically paced oscillatory flow modes, and integrates matched unidirectional-shear references within the same chip. Using this system, we show that oscillatory WSS topology destabilizes endothelial monolayers, drives asymmetric collective emergent behaviors, impairs actin-nuclear mechanotransduction, accompanied by nuclear softening and enhanced perinuclear nanoparticle uptake. Integrated live-cell imaging, fluorescence analysis, Brillouin microscopy, and transport assays enable multimodal phenotyping across collective, subcellular mechanical and functional scales. By making disease-relevant WSS topology experimentally controllable, this vascular-chip framework bridges computational hemodynamics and experimental mechanomedicine, supporting standardized vascular disease modeling and functional screening.

Pose-estimation pipelines usually export keypoint coordinates and discard the intermediate visual representations learned to localize animals in a specific assay. We asked whether those discarded representations can be reused for full-video ethology. BehaviorScope-X tests this idea by treating a trained pose checkpoint as both a keypoint estimator and a reusable visual encoder: the pose model is run once to cache detections, keypoints, pose-derived social geometry, and frozen intermediate descriptors, after which compact temporal classifiers are trained on cached multimodal windows. Across MARS resident-intruder videos, cached pose-trained descriptors and pose-derived geometry provided complementary evidence for behavior decoding, recovering sustained behavioral episodes and local sequence structure while revealing a main limitation in dense short-bout regions. The same cache-and-classify design generalized across pose routes, including a MobileNetV3 backbone and a DeepLabCut SuperAnimal HRNet-W32 checkpoint, showing that standard pose workflows can expose behavior-relevant visual descriptors without giving up their keypoint-estimation role. We further tested the approach in Fly-v-Fly aggression, extending the analysis to a second species and shorter behavioral time scale, where sub-second events and annotation-boundary uncertainty limited strict bout recovery. End-to-end profiling showed that the workflow can operate near real time or in real time on consumer hardware. Together, these experiments support amortized pose vision as a practical strategy for reusing assay-trained pose models as stable sources of visual and geometric evidence for scalable behavioral analysis.

Integrating tissue-level organisation with sub-cellular resolution and molecular information often requires combining multiple microscopy modalities and scales. However, aligning images acquired with different modalities, settings, or instruments remains challenging. Here, we introduce NucleiSky, a microscopy image registration framework that utilises the spatial arrangement of nuclei or other landmarks as an intrinsic biological fingerprint. NucleiSky represents images as constellations of centroids and aligns them using geometric algorithms and spatial consensus scoring. In benchmark datasets, NucleiSky could localise query regions within larger reference images using as few as five nuclei. We show that NucleiSky can locate high-magnification fields of view within low-magnification overview scans, map these alignments to additional channels, support live brightfield-to-fixed registration using synthetic nuclear labels, and guide microscope retargeting. We further show that the same constellation-matching principle can be extended to 3D localisation and to non-nuclear landmarks. These findings establish local landmark geometry as an intrinsic spatial fingerprint that enables localisation and registration across imaging scales, modalities and microscopy platforms. NucleiSky is available as an open-source Python package and as notebook-based applications.

We developed a convolutional neural network-based machine learning technique to simultaneously analyze the morphology and motility of spirochetal bacteria swimming with continuous cellular deformation. Matching probabilities between experimental images and learned models realizes quantification of cell morphology and association with motility. This method can be applied to diverse transformable cells, offering critical biophysical insights into microbial dynamics.

Spatial organisation is a defining feature of biological systems, underpinning cellular interactions, tissue function, disease progression and therapeutic response. Identifying and quantifying spatial organisation may require methods that resolve relationships across spatial scales. The pair correlation function (PCF) quantifies spatial dependence between points across multiple length scales, but its standard Euclidean formulation is poorly suited to data defined on irregular, curved or otherwise structured domains, where tissue geometry may constrain biological organisation and distort Euclidean distances. Here, we introduce netPCF, a geometry-aware extension of the PCF for quantifying spatial organisation on complex biological domains. By representing tissue structures, anatomical surfaces and other constrained geometries as spatial networks, netPCF generalises the PCF beyond extrinsic Euclidean settings. The framework derives the expected behaviour of the statistic under complete spatial randomness using interpretable finite-support kernels, provides bootstrap-based uncertainty quantification, and includes practical criteria for assessing domain discretisation adequacy. We further extend netPCF to marked (labelled) biological data using feature kernels for categorical and continuous attributes, enabling unified analysis of cell identities, marker intensities, phenotypic states, gene expression and other quantitative features on structured domains in any spatial dimension. All methods are implemented in the open-source Python package spacenet. Synthetic studies show that netPCF recovers classical Euclidean behaviour on sufficiently resolved networks and is robust to common imaging noise. We demonstrate its utility in two biological applications. In three-dimensional imaging mass cytometry data from HER2+ breast carcinoma, netPCF separates tissue architecture-driven proximity from biologically meaningful endothelial and immune cell organisation. In reconstructed surfaces of developing murine embryos, netPCF identifies a transition in the Wnt1-Wnt6 relationship from short-range co-localisation at E9.5 to spatial exclusion at E11.5, a pattern of ectodermal boundary refinement not captured by prior voxel-wise co-expression analysis. Overall, netPCF provides a statistically grounded and practical framework for quantifying spatial organisation on complex biological domains.

Spectral bleed-through remains a persistent practical problem in multichannel fluorescence microscopy. Signal from one fluorophore can be recorded in the detection channel of another, thereby biasing intensity measurements, inflating apparent colocalization, and complicating the interpretation of dynamic microscopy data. Although many correction strategies exist, routine workflows often remain fragmented across ad hoc scripts, manually tuned graphical procedures, or method-specific blind-unmixing implementations with limited provenance. Here we present spectral-unmixing, an open-source Python package for reproducible linear spectral unmixing in multidimensional microscopy stacks. The package unifies directed two-channel correction with multiple alpha-estimation strategies, optional bidirectional two-channel correction through explicit inversion of a 2 x 2 mixing model, and PICASSO-family blind unmixing for multichannel data. Microscopy inputs are normalized at the API boundary to canonical TZCY X stacks, allowing the same unmixing code to be applied across file formats without manual axis handling. Machine-readable sidecar reports preserve the effective processing configuration and estimated coefficients for every output, so that workflows can be audited and reproduced. Synthetic and real-data-derived benchmarks show that the implemented workflows accurately estimate and correct bleed-through when their model assumptions are satisfied. In fixed-alpha two-channel simulations, the mean-ratio and linear-fit estimators recovered {approx} 0.283 for a ground-truth value of 0.28 and reduced target-channel normalized root mean squared error from approximately 0.029 to 0.003. In time-varying simulations, per-time-point estimation tracked coefficient drift substantially better than reference-time-point estimation. Bidirectional inversion recovered reciprocally mixed channels accurately when coefficients were known or well estimated. PICASSO-family benchmarks further showed a practical trade-off between reducing residual inter-channel dependence and preserving fluorophore identity, with MATLAB-style workflows behaving more conservatively and source-sink formulations providing stronger dependence suppression when meaningful directional priors are available. Together, these elements make spectral-unmixing a practical, transparent, and extensible platform for reproducible spectral unmixing of fluorescence microscopy data in neuroscience and other quantitative bioimage-analysis settings.

Directed evolution consisting of iterative rounds of diversification, selection, and counter-selection, underlies modern protein and antibody engineering, yet small-molecule drug design still advances largely through high-throughput screening and medicinal-chemistry intuition. Transformer softmax attention is mathematically identical to the Boltzmann distribution that governs molecular binding at thermal equilibrium1, an isomorphism that prescribes a sequence-native Specificity Foundation Model (SFM)2. This framework was recently applied across seven molecular recognition domains3,4 and scaled into the drug-target SFM (dtSFM), the first to pair a full-scale encoder with a generative decoder5. Whether such a model can be driven, iteratively and under selection, to optimize leads rather than sample them once has not been shown. Here we present GenLoop, a closed generative drug design loop that turns single-pass generation into directed evolution of chemistry. dtSFM generates target-conditioned molecules and reranks them by their thermodynamic compatibility score. An orthogonal structural verifier, AlphaFold 3, is used that shares no architecture or training data with dtSFM. Cheminformatics filters enforce developability, and generative evolution is performed on the structurally verified candidates, selecting for predicted binders and counter-selecting against off-target chemistry. Applied across twelve drug targets spanning pharmacologically distinct mechanism classes, GenLoop produced AlphaFold 3-verified designs that reached the structural confidence of the approved drug for five of the twelve targets, with the best designs at interface iPTM 0.93-0.98 and PAE 0.8-2.0 [A], as well as resolving paralog selectivity across nine targets. Two full disease campaigns followed. For the cystic-fibrosis transmembrane conductance regulator, GenLoop designed nine developability-filtered and structurally novel lead candidates (iPTM up to 0.93, interface PAE 2.3 [A]) targeting all three orthogonal sites of the approved drug Trikafta. For the GLP-1 receptor family, dtSFM engineered tunable single-, dual-, and triple-receptor incretin designs, yielding 23 central-pocket candidates that are structurally novel at median iPTM 0.89 and interface PAE 1.95 [A]. GenLoop with dtSFM brings directed evolution to small molecules through computational-thermodynamic selection; wet-lab validation is the immediate next step.

Tuberculosis (TB) is a major global health challenge, with many cases remaining undiagnosed due to limited access to screening and diagnostic services. Artificial intelligence (AI) systems based on cough sound analysis offer a scalable and accessible approach to TB screening, but most previous studies have analysed isolated cough events, despite the possibility that diagnostically useful information is encoded in the temporal dynamics of cough episodes. We evaluated an AI-based screening framework using cough recordings collected under real-world clinical conditions from 500 participants in Zambia, including 201 individuals with bacteriologically confirmed TB, 150 symptomatic patients with other respiratory diseases, and 149 healthy controls. Using multiple pre-trained speech foundation models fine-tuned on cough sounds, we systematically investigated the influence of temporal context by varying the audio input window from 1 to 6 s, measured from the onset of each cough episode. Across all evaluated models, diagnostic performance consistently peaked with a 3 s input window, indicating that useful information extends beyond individual cough events and is encoded within the short-term temporal dynamics of cough episodes. The best audio-only model achieved an area under the receiver operating characteristic curve (AUROC) of 85.2% for distinguishing TB from all other participants and 80.1% for distinguishing TB from symptomatic non-TB respiratory disease. Incorporating demographic and clinical variables improved AUROC to 92.1% and 84.2%, respectively. Performance remained robust across recording devices, participants with HIV co-infection, and varying acoustic conditions. These findings demonstrate that preserving temporal context improves AI-based cough screening for TB and suggest that analysing cough episodes, rather than isolated cough events, may enhance diagnostic performance in real-world settings. More broadly, the results highlight the importance of temporal context in the design of future respiratory sound datasets and AI-based diagnostic systems.

Clinical treatment planning of near-infrared (NIR) brain stimulation requires patient-specific light dosimetry to optimize fluence delivery to cortical targets. The gold-standard Monte Carlo (MC) photon transport forward solver is accurate but computationally expensive and non-differentiable for personalized inverse design across subjects. Here, we present a foundation-model (FM)-encoded, differentiable implicit-neural surrogate for the MC solver. A pretrained 3D MRI/CT foundation model, VISTA3D, is domain-adapted to head phantoms with known optical properties to encode the subject anatomy. Next, an implicit neural representation is used to predict light fluence at arbitrary continuous coordinates. This formulation enables off-grid queries and gradients with respect to illumination parameters. Trained with a physics-informed, decade-stratified loss, the surrogate attains R2 {approx} 0.90 on held-out subjects. Ablation results show that the FM benefit is contingent on domain adaptation. Benchmarked against standard learned surrogates, our model is the most accurate in the high-dose region and best on dose-fidelity metrics ({gamma}-index, treated-volume DICE). Finally, gradient-based optimization through the surrogate recovers MC-consistent illumination configurations 50-240 x faster.

Programmable molecular biology increasingly requires strategies for converting engineered recognition or proximity modules into measurable outputs, particularly within transcriptional regulation, RNA imaging, and CRISPR-associated systems. Synthetic chemically induced dimerization (CID) systems provide a class of programmable recognition modules for such applications, yet generalized strategies for coupling structurally diverse CIDs to functional readouts remain limited. Here, we introduce a CID-to-output conversion strategy based on engineering of the linker-mediated coupling interface. Using single-fluorescent-protein sensors as an experimentally tractable optical model readout, we systematically varied paired N- and C-terminal linkers flanking circularly permuted green fluorescent protein (cpGFP) to map coupling landscapes across synthetic CID systems derived from combinatorial selection and computational protein design. The results revealed strong non-additive interactions across paired linkers and suggest that linker length is a first-order determinant of CID-to-output coupling. Across nanobody-, monobody-, and de novo-designed CID architectures, this framework yielded functional sensors with dynamic ranges up to 1270% and robust responses in mammalian cells. Together, this work demonstrates that effective CID-to-output conversion can be achieved by empirically mapping the linker-mediated coupling interface, providing a practical route for adapting synthetic CID to diverse programmable molecular readouts and nucleic-acid-associated synthetic biology systems O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=94 SRC="FIGDIR/small/735888v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@1111094org.highwire.dtl.DTLVardef@1579e8aorg.highwire.dtl.DTLVardef@16981feorg.highwire.dtl.DTLVardef@1d588f7_HPS_FORMAT_FIGEXP M_FIG C_FIG